Literature DB >> 16082341

Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria.

Nicholas Onaca1, Edmund Q Sanchez, Larry B Melton, George J Netto, Karl A Glastad, Patriciu A Martin, Takehisa Ueno, Marlon F Levy, Robert M Goldstein, Goran B Klintmalm.   

Abstract

Liver transplantation (LTX) corrects the enzymatic defect responsible for type 1 primary hyperoxaluria (PH1). It has been advocated in combination with kidney transplantation (KTX) in patients with renal failure from PH1 because KTX alone can result in early graft loss. A 58-year-old male patient with PH1 on hemodialysis underwent resection of the left lateral segment of the liver followed by orthotopic auxiliary left lateral segment liver transplantation and kidney transplantation from a deceased donor. The serum oxalate dropped from 34.8 micromol/L before transplant to 3.6-8.3 in the first months posttransplant to <1 micromol/L (normal range 0.4-3.0). One year after posttransplant, the patient has an iothalamate glomerular filtration rate of 58 ml/min. Orthotopic auxiliary LTX is an alternative to whole LTX in PH1. By using a split deceased donor liver, it does not deprive the donor pool and protects the recipient from liver failure in case of graft loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082341     DOI: 10.1097/01.tp.0000168147.88707.80

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  Partial liver transplantation.

Authors:  Nianqiao Gong; Xiaoping Chen
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

2.  Left Lateral Sectionectomy of the Native Liver and Combined Living-Related Liver-Kidney Transplantation for Primary Hyperoxaluria Type 1.

Authors:  Guo-Yong Chen; Si-Dong Wei; Zhong-Wu Zou; Gao-Feng Tang; Jian-Jun Sun; Shao-Tang Zhou
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 3.  Combined liver-kidney transplantation for rare diseases.

Authors:  Mladen Knotek; Rafaela Novak; Alemka Jaklin-Kekez; Anna Mrzljak
Journal:  World J Hepatol       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.